Wockhardt swings to profit in Q2

14 Nov 2011 Evaluate

Drug firm, Wockhardt has reported a net profit of Rs 53.80 crore for the second quarter ended September 30, 2011. It had posted a net loss of Rs 67.86 crore for the same quarter last fiscal. The company’s total income has increased by 33.63% at Rs 640.73 crore for Q2FY12 as compared to Rs 479.49 crore for Q2FY11.

The group has reported a consolidated net profit of Rs 127.58 crore for the quarter under teview on improved sales in all markets led by the US. The company had posted a net loss of Rs 96.68 crore for the corresponding quarter previous year.

Wockhardt USA reported a sales growth of 49% with its prime products improving market share in a highly competitive market scenario. There were three abbreviated new drug application (ANDA) filings and four approvals for the quarter, the company said.

The company's India business grew by 13.5% in the second quarter this fiscal, capturing a market share of 2.03% as compared to 1.94% last year.

Wockhardt Share Price

1445.90 67.40 (4.89%)
31-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.75
Dr. Reddys Lab 1271.05
Cipla 1510.90
Zydus Lifesciences 914.65
Lupin 2112.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×